Phase 4Completed
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. (ADHERE)
A Multicenter, Two Arm, Randomized, Open Label Clinical Study Investigating Renal Function in an Advagraf® Based Immunosuppressive Regimen With or Without Sirolimus in Kidney Transplant Patients
- Sponsor
- Astellas Pharma Inc (Industry)
- Enrollment
- 853 enrolled
- Conditions
- Kidney Transplantation
- Interventions
- Advagraf; Mycophenolate Mofetil; Sirolimus; Corticosteroids
- Ages
- adults, older adults
- Registry
- NCT01363752, EUCTR2010-019639-37
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to compare the effect of two anti-rejection therapy regimens on kidney function in kidney transplant recipients.
Primary outcomes
- Glomerular Filtration Rate (GFR) estimated by iohexol clearance at Week 52 post kidney transplantation
History
Last registry update
Primary completion
Registered
Started